Florida becomes 1st state authorized by FDA to import meds from Canada

Florida has become the first state authorized by the FDA to import prescription drugs from Canada after the agency issued an approval of the Sunshine State's drug importation program Jan. 5.

The FDA made the decision under section 804 of the Federal Food, Drug, and Cosmetic Act, which allows states and Indian tribes to import certain prescription drugs from Canada if the submitted program proposal to do so demonstrates significant cost savings for U.S. consumers while maintaining patient safety. 

The decision comes after the state also filed a lawsuit against the FDA for alleging it was "recklessly" delaying the decision. Which is not the first time the state has been at odds with the agency.

"Florida has demonstrated that it meets the statutory obligation to ensure that importation under section 804 will significantly reduce the cost of covered products to the American consumer without posing additional risk to the public’s health and safety," a Jan. 5 letter from the FDA to Jason Weida, the secretary for the Florida Agency for Health Care Administration, reads.

Florida's importation proposal will be authorized for two full years on the date it notifies the FDA of the first shipment to be imported, according to the news release. However, before it begins importing the cheaper medicines, the state must submit additional information about the drugs it wants to import, re-label drugs to be consistent with U.S. and FDA standards, test the drugs for authenticity and compliance, and submit reports quarterly to the FDA on the cost savings and safety. 

The state previously estimated in the first year of the program alone that its savings would total $150 million. It is planning to import drugs for HIV, AIDS, psychiatric medications, hepatitis C and more, The New York Times reported.

Other states including Colorado, Texas, North Dakota, New Mexico, New Hampshire, Maine, Wisconsin and Vermont are also pursuing similar approvals from the FDA.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars

>